BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31852153)

  • 1. A case report of primary prostate intravascular large B cell lymphoma presenting as prostatic hyperplasia.
    Zhu F; Pan H; Xiao Y; Li Q; Liu T; Liu X; Wu G; Li J; Zhang L
    Medicine (Baltimore); 2019 Dec; 98(50):e18384. PubMed ID: 31852153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
    Shimada K; Yamaguchi M; Atsuta Y; Matsue K; Sato K; Kusumoto S; Nagai H; Takizawa J; Fukuhara N; Nagafuji K; Miyazaki K; Ohtsuka E; Okamoto M; Sugita Y; Uchida T; Kayukawa S; Wake A; Ennishi D; Kondo Y; Izumi T; Kin Y; Tsukasaki K; Hashimoto D; Yuge M; Yanagisawa A; Kuwatsuka Y; Shimada S; Masaki Y; Niitsu N; Kiyoi H; Suzuki R; Tokunaga T; Nakamura S; Kinoshita T
    Lancet Oncol; 2020 Apr; 21(4):593-602. PubMed ID: 32171071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular large B-cell lymphoma presenting as multiple stroke: A case report.
    Yunce M; Muganlinskaya N; Selinger S
    Medicine (Baltimore); 2018 Oct; 97(41):e12793. PubMed ID: 30313105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary diffuse large B cell lymphoma (DLBCL) of the prostate presenting with lower urinary tract symptoms (LUTS).
    Nusrat A; Nazim SM
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
    Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
    Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare primary extranodal lymphomas: diffuse large B-cell lymphomas of the genital tract.
    Rajnics P; Demeter J; Csomor J; Krenács L; Pajor L; Kollár B; Kertész Z; Egyed M
    Ann Hematol; 2009 Dec; 88(12):1223-8. PubMed ID: 19352660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravascular B-cell lymphoma with hypercalcemia as the initial presentation.
    Chinen Y; Nakao M; Sugitani-Yamamoto M; Kiyota M; Horiike S; Kuroda J; Taniwaki M
    Int J Hematol; 2011 Dec; 94(6):567-70. PubMed ID: 22045306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status.
    Kaito S; Muto H; Miyawaki S; Ohashi K; Tomiyama J
    Am J Case Rep; 2019 Jun; 20():780-784. PubMed ID: 31155607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma with Large Cell Transformation of the Prostate : A Case Report].
    Kinjo T; Yamanaka Y; Katayama K; Minato N; Mori N; Yoshioka T; Onishi M; Sugahara H; Fujita S
    Hinyokika Kiyo; 2015 Jul; 61(7):293-8. PubMed ID: 26278216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental finding of non-Hodgkin's lymphoma in a patient affected by castration-sensitive prostate cancer: A case report.
    Pirozzi A; Cartenì G; Scagliarini S; Fusco M; Riccardi F
    Medicine (Baltimore); 2019 Mar; 98(11):e14805. PubMed ID: 30882658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary non-Hodgkin's lymphoma of the prostate].
    Swierz J; Zieliński H; Dabek A
    Pol Merkur Lekarski; 1996 Oct; 1(4):278-9. PubMed ID: 9156946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary diffuse large B-cell lymphoma of the prostate: a case report and review of the literature.
    Ren M; Liu Y
    J Med Case Rep; 2021 Nov; 15(1):546. PubMed ID: 34727993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate involvement by intravascular large B-cell lymphoma: a case report with literature review.
    Xu M; Yang Q; Li M; Geng W; Huang W; Chen Y
    Int J Surg Pathol; 2011 Aug; 19(4):544-7. PubMed ID: 21632638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary intravascular large B-cell lymphoma accompanying synchronous primary pulmonary adenocarcinoma and benign interstitial lesions.
    Satoh T; Arai E; Kayano H; Sakaguchi H; Takahashi N; Tsukasaki K; Yasuda M
    J Clin Exp Hematop; 2019 Sep; 59(3):140-144. PubMed ID: 31391407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases].
    Yang JJ; Chen XC; Tang Y; Shen K; Xie LP; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):145-147. PubMed ID: 29737107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
    Miura K; Takahashi H; Nakagawa M; Hamada T; Uchino Y; Iizuka K; Ohtake S; Iriyama N; Hatta Y; Nakamura H
    Expert Rev Anticancer Ther; 2022 Jun; 22(6):583-595. PubMed ID: 35472312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
    Poeschel V; Held G; Ziepert M; Witzens-Harig M; Holte H; Thurner L; Borchmann P; Viardot A; Soekler M; Keller U; Schmidt C; Truemper L; Mahlberg R; Marks R; Hoeffkes HG; Metzner B; Dierlamm J; Frickhofen N; Haenel M; Neubauer A; Kneba M; Merli F; Tucci A; de Nully Brown P; Federico M; Lengfelder E; di Rocco A; Trappe R; Rosenwald A; Berdel C; Maisenhoelder M; Shpilberg O; Amam J; Christofyllakis K; Hartmann F; Murawski N; Stilgenbauer S; Nickelsen M; Wulf G; Glass B; Schmitz N; Altmann B; Loeffler M; Pfreundschuh M; ;
    Lancet; 2019 Dec; 394(10216):2271-2281. PubMed ID: 31868632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
    Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
    Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
    Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
    Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.